Hospital & Healthcare Management October 28, 2023
Content Team HHMGlobal

The MHRA, FDA, as well as Health Canada have jointly gone on to publish five guiding principles for machine learning-enabled medical device- MLMD manufacturers so as to develop predetermined change control plans- PCCPs.

The idea behind these guiding principles is to assist manufacturers of MLMDs by decreasing the regulatory requirements for reconsideration in case of specific modifications or improvements to their respective devices.

Building upon the 10 guiding principles for good machine learning practice, the 5 guiding principles for manufacturers of MLMD state that a properly constructed and carefully planned approach must be:

  1. Bounded and focused: Describing the particular modifications that manufacturers intend to make.
  2. Risk-based: The intent, design, and execution of a PCCP are guided by an approach...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
Olympus and Ziosoft partner to convert CT and MR scans into surgical 3D models
MicroTransponder secures $65 million to expand stroke recovery therapy
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
Dr. Oz stresses need for faster Medicare coverage of new devices during confirmation hearing
People Are Getting Brain Implants For BCI

Share This Article